Form 4 HALOZYME THERAPEUTICS For: Aug 14 Filed by: Engler Robert
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140818/A9ZC322CZ222R2Z2222522ZZRUQIZJ3R3262
Filed on: August 18, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BGHL (EUR): NAV(s)
- deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer
- ValueAct Announces Support for the Substantial Changes in Strategy and Board Leadership Announced by Seven & i
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
